Breathe Easy - VIDA Blog
2023 Year In Review
Read More
VIDA Launches Cloud-Based Case Viewer to Improve Clinical Trial Imaging Workflows
Read More
Adoption of VIDA's AI to Improve Patient Outcomes and Reduce Burnout
Read More
Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team
Read More
Black Lives Matter
Read More
AI-Powered Respiratory Imaging in and Beyond the Era of COVID-19
Read More
VIDA COMPLETES SECOND CLOSE OF ROUND C FINANCING
Read More
VIDA Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite
Read More
Anthony Chang, MD, Founder of AIMed, Speaks with Susan Wood, PhD, CEO of VIDA, About COVID-19
Read More
A Note to Our Customers and Partners Regarding COVID-19
Read More
VIDA ANNOUNCES SERIES C FINANCING TO ACCELERATE ACCESS TO AI-POWERED LUNG IMAGING ANALYSIS
Read More
Perspectives: An Interview with John Newell, MD FACR on Hot Topics in Thoracic Imaging
Read More
Literature Review: COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease
Read More
VIDA PARTNERS WITH TERARECON, INC. FOR DISTRIBUTION OF AI-POWERED LUNG ANALYSIS
Read More
VIDA Expands Board, Announcing Erkan Akyuz As Independent Director
Read More
Perspectives: An Interview with Prof. Felix Herth on the past, present and future of ELVR therapies
Read More
VIDA Announces Strategic Investment From UnityPoint Health Ventures
Read More
LungPrint by VIDA Featured on the Nuance "What's Next" Blog
Read More